Senti Biosciences
3 known investors
Senti Bio develops cell and gene therapies for cancer and difficult-to-treat diseases using synthetic biology and engineered Gene Circuits to enhance precision, control, and selectivity in targeting tumor cells. The company is a clinical-stage biotech firm leveraging proprietary platform technology across multiple cell types and modalities.
Founders & leadership
TL
Tim LuCo-Founder and Chief Executive Officer
KR
Kanya RajangamPresident, Head of Research & Development and Chief Medical Officer